Recent Finacing
Recent Raise
PhaSER Biomedical develops and distributes the 8HUM humanized transgenic mouse platform that models human drug metabolism and disposition to assess efficacy, predict drug–drug interactions, and inform clinical trial design.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor